« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 49, Issue 4
, Pages
937-946
, 15 March 2001
Updated results of the phase III Radiation Therapy Oncology Group (RTOG) trial 85-31 evaluating the potential benefit of androgen suppression following standard radiation therapy for unfavorable prognosis carcinoma of the prostate
To access this article, please choose from the options below
PII: S0360-3016(00)01516-9
doi: 10.1016/S0360-3016(00)01516-9
© 2001 Elsevier Science Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 49, Issue 4
, Pages
937-946
, 15 March 2001
